vs
微宏控股(MVST)与RIGEL PHARMACEUTICALS INC(RIGL)财务数据对比。点击上方公司名可切换其他公司
微宏控股的季度营收约是RIGEL PHARMACEUTICALS INC的1.4倍($96.4M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs 17.2%,领先366.9%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs -15.0%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs 8.9%)
微宏控股是一家电池科技企业,总部位于美国得克萨斯州斯塔福德,在纳斯达克上市。公司主要面向商用电动汽车与并网储能系统,设计、研发并生产电池组件及电池系统,目前在美国、中国、德国均设有生产基地。
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
MVST vs RIGL — 直观对比
营收规模更大
MVST
是对方的1.4倍
$69.8M
营收增速更快
RIGL
高出36.2%
-15.0%
净利率更高
RIGL
高出366.9%
17.2%
两年增速更快
RIGL
近两年复合增速
8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $96.4M | $69.8M |
| 净利润 | $16.5M | $268.1M |
| 毛利率 | 1.0% | 91.5% |
| 营业利润率 | -42.7% | 33.2% |
| 净利率 | 17.2% | 384.0% |
| 营收同比 | -15.0% | 21.2% |
| 净利润同比 | 120.1% | 1769.2% |
| 每股收益(稀释后) | $0.19 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MVST
RIGL
| Q4 25 | $96.4M | $69.8M | ||
| Q3 25 | $123.3M | $69.5M | ||
| Q2 25 | $91.3M | $101.7M | ||
| Q1 25 | $116.5M | $53.3M | ||
| Q4 24 | $113.4M | $57.6M | ||
| Q3 24 | $101.4M | $55.3M | ||
| Q2 24 | $83.7M | $36.8M | ||
| Q1 24 | $81.4M | $29.5M |
净利润
MVST
RIGL
| Q4 25 | $16.5M | $268.1M | ||
| Q3 25 | $-1.5M | $27.9M | ||
| Q2 25 | $-106.1M | $59.6M | ||
| Q1 25 | $61.8M | $11.4M | ||
| Q4 24 | $-82.3M | $14.3M | ||
| Q3 24 | $13.2M | $12.4M | ||
| Q2 24 | $-101.6M | $-1.0M | ||
| Q1 24 | $-24.8M | $-8.2M |
毛利率
MVST
RIGL
| Q4 25 | 1.0% | 91.5% | ||
| Q3 25 | 37.6% | 93.2% | ||
| Q2 25 | 34.7% | 95.6% | ||
| Q1 25 | 36.9% | 91.7% | ||
| Q4 24 | 36.6% | 89.9% | ||
| Q3 24 | 33.2% | 85.5% | ||
| Q2 24 | 32.5% | 92.4% | ||
| Q1 24 | 21.2% | 93.1% |
营业利润率
MVST
RIGL
| Q4 25 | -42.7% | 33.2% | ||
| Q3 25 | 10.5% | 40.9% | ||
| Q2 25 | 17.8% | 60.1% | ||
| Q1 25 | 16.3% | 23.9% | ||
| Q4 24 | -1.2% | 28.9% | ||
| Q3 24 | 7.1% | 25.4% | ||
| Q2 24 | -118.0% | 1.2% | ||
| Q1 24 | -28.4% | -23.6% |
净利率
MVST
RIGL
| Q4 25 | 17.2% | 384.0% | ||
| Q3 25 | -1.2% | 40.2% | ||
| Q2 25 | -116.1% | 58.6% | ||
| Q1 25 | 53.0% | 21.5% | ||
| Q4 24 | -72.6% | 24.9% | ||
| Q3 24 | 13.1% | 22.5% | ||
| Q2 24 | -121.4% | -2.8% | ||
| Q1 24 | -30.5% | -27.9% |
每股收益(稀释后)
MVST
RIGL
| Q4 25 | $0.19 | $14.11 | ||
| Q3 25 | $0.00 | $1.46 | ||
| Q2 25 | $-0.33 | $3.28 | ||
| Q1 25 | $0.05 | $0.63 | ||
| Q4 24 | $-0.24 | $0.82 | ||
| Q3 24 | $0.03 | $0.70 | ||
| Q2 24 | $-0.32 | $-0.06 | ||
| Q1 24 | $-0.08 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $105.0M | $155.0M |
| 总债务越低越好 | $13.2M | $52.5M |
| 股东权益账面价值 | $410.5M | $391.5M |
| 总资产 | $1.0B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.03× | 0.13× |
8季度趋势,按日历期对齐
现金及短期投资
MVST
RIGL
| Q4 25 | $105.0M | $155.0M | ||
| Q3 25 | $90.7M | $137.1M | ||
| Q2 25 | $99.7M | $108.4M | ||
| Q1 25 | $90.9M | $77.1M | ||
| Q4 24 | $73.0M | $77.3M | ||
| Q3 24 | $63.6M | $61.1M | ||
| Q2 24 | $68.2M | $49.1M | ||
| Q1 24 | $39.5M | $49.5M |
总债务
MVST
RIGL
| Q4 25 | $13.2M | $52.5M | ||
| Q3 25 | $34.4M | $60.0M | ||
| Q2 25 | $34.2M | $60.0M | ||
| Q1 25 | $41.3M | $60.0M | ||
| Q4 24 | $41.1M | $60.0M | ||
| Q3 24 | $53.4M | $60.0M | ||
| Q2 24 | $34.2M | $60.0M | ||
| Q1 24 | $43.0M | $60.0M |
股东权益
MVST
RIGL
| Q4 25 | $410.5M | $391.5M | ||
| Q3 25 | $358.1M | $117.6M | ||
| Q2 25 | $356.1M | $81.9M | ||
| Q1 25 | $454.2M | $18.6M | ||
| Q4 24 | $387.9M | $3.3M | ||
| Q3 24 | $486.1M | $-14.6M | ||
| Q2 24 | $455.0M | $-29.9M | ||
| Q1 24 | $546.1M | $-31.7M |
总资产
MVST
RIGL
| Q4 25 | $1.0B | $513.6M | ||
| Q3 25 | $1.0B | $242.5M | ||
| Q2 25 | $1.0B | $206.7M | ||
| Q1 25 | $982.9M | $176.0M | ||
| Q4 24 | $951.9M | $164.0M | ||
| Q3 24 | $997.9M | $139.4M | ||
| Q2 24 | $961.4M | $128.4M | ||
| Q1 24 | $1.0B | $126.5M |
负债/权益比
MVST
RIGL
| Q4 25 | 0.03× | 0.13× | ||
| Q3 25 | 0.10× | 0.51× | ||
| Q2 25 | 0.10× | 0.73× | ||
| Q1 25 | 0.09× | 3.23× | ||
| Q4 24 | 0.11× | 18.25× | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.08× | — | ||
| Q1 24 | 0.08× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $16.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $15.8M | — |
| 自由现金流率自由现金流/营收 | 16.4% | — |
| 资本支出强度资本支出/营收 | 0.7% | — |
| 现金转化率经营现金流/净利润 | 0.99× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $56.1M | — |
8季度趋势,按日历期对齐
经营现金流
MVST
RIGL
| Q4 25 | $16.4M | $22.0M | ||
| Q3 25 | $15.2M | $24.0M | ||
| Q2 25 | $37.2M | $30.5M | ||
| Q1 25 | $7.2M | $-893.0K | ||
| Q4 24 | $6.1M | $14.5M | ||
| Q3 24 | $-5.4M | $21.7M | ||
| Q2 24 | $111.0K | $302.0K | ||
| Q1 24 | $2.0M | $-5.0M |
自由现金流
MVST
RIGL
| Q4 25 | $15.8M | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $34.3M | — | ||
| Q1 25 | $4.8M | — | ||
| Q4 24 | $5.7M | — | ||
| Q3 24 | $-19.6M | — | ||
| Q2 24 | $-2.8M | — | ||
| Q1 24 | $-8.2M | — |
自由现金流率
MVST
RIGL
| Q4 25 | 16.4% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 37.5% | — | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 5.1% | — | ||
| Q3 24 | -19.3% | — | ||
| Q2 24 | -3.4% | — | ||
| Q1 24 | -10.1% | — |
资本支出强度
MVST
RIGL
| Q4 25 | 0.7% | — | ||
| Q3 25 | 11.3% | — | ||
| Q2 25 | 3.1% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 14.0% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 12.6% | — |
现金转化率
MVST
RIGL
| Q4 25 | 0.99× | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | 0.12× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | -0.41× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MVST
| Europe | $35.1M | 36% |
| CN | $32.5M | 34% |
| US | $21.5M | 22% |
| Other | $7.2M | 8% |
RIGL
暂无分部数据